WG
SPPI

Winton Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Winton Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-109,140
Closed -$81.9K – 1191
2023
Q1 		$81.9K Buy
109,140
+13,746
+14% +$10K 0.01% 932
2022
Q4 		$35.2K Buy
95,394
+6,048
+7% +$2.55K ﹤0.01% 895
2022
Q3 		$38K Sell
89,346
-7,225
-7% -$7.1K ﹤0.01% 917
2022
Q2 		$75K Buy
96,571
+69,452
+256% +$61.2K ﹤0.01% 927
2022
Q1 		$35K Buy
+27,119
New +$25K ﹤0.01% 934
2020
Q1 		– Sell
-12,829
Closed -$47K – 1580
2019
Q4 		$47K Buy
+12,829
New +$104K ﹤0.01% 1508
2019
Q1 		– Sell
-14,703
Closed -$129K – 1216
2018
Q4 		$129K Buy
+14,703
New +$187K ﹤0.01% 835
2018
Q3 		– Sell
-14,487
Closed -$304K – 1171
2018
Q2 		$304K Sell
14,487
-5,000
-26% -$92.6K 0.01% 825
2018
Q1 		$314K Buy
+19,487
New +$386K 0.01% 962
2017
Q4 		– Sell
-231,947
Closed -$3.26M – 721
2017
Q3 		$3.26M Buy
+231,947
New +$2.1M 0.1% 224

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Winton Group's SPPI Position: Q2 2023 in Review

Winton Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2023, closing a stake of 109,140 shares — an estimated $81.9K sold.

Winton Group first reported a position in SPPI in Q3 2017 and held it in 10 quarters. The position peaked at $3.26M in Q3 2017. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

  • Winton Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2023 after selling out during the quarter.
  • Winton Group sold 109,140 Spectrum Pharmaceuticals Inc shares in Q2 2023, an estimated $81.9K.
  • Winton Group first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 10 quarters.
  • Winton Group's Spectrum Pharmaceuticals Inc position peaked at $3.26M in Q3 2017.
  • 78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on Winton Group's 13F filing for Q2 2023, filed 14 Aug 2023.